Bristol Myers Squibb get EC approval for Opdivo (nivolumab) plus Yervoy (ipilimumab) with chemotherapy for metastatic NSCLC Read more
Pfizer and BioNTech to potentially supply EU with 200 mn doses of COVID-19 vaccine candidate Read more
Janssen gets EC approval for expanded use of IMBRUVICA (ibrutinib) plus rituximab to treat CLL Read more